Business Description
SMO Clinplus Co Ltd
ISIN : CNE100005CP8
Share Class Description:
SZSE:301257: Class ACompare
Compare
Traded in other countries / regions
301257.China IPO Date
2022-05-17Description
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 99.63 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 391.91 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 8.5 | |||||
| Beneish M-Score | -2.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.6 | |||||
| 3-Year EBITDA Growth Rate | 37.1 | |||||
| 3-Year EPS without NRI Growth Rate | 39.4 | |||||
| 3-Year FCF Growth Rate | 61.3 | |||||
| 3-Year Book Growth Rate | 68.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.78 | |||||
| 9-Day RSI | 45.8 | |||||
| 14-Day RSI | 44.83 | |||||
| 6-1 Month Momentum % | -29.59 | |||||
| 12-1 Month Momentum % | -41.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.09 | |||||
| Quick Ratio | 5.09 | |||||
| Cash Ratio | 3.46 | |||||
| Days Sales Outstanding | 49.3 | |||||
| Days Payable | 1.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.39 | |||||
| Dividend Payout Ratio | 0.08 | |||||
| Forward Dividend Yield % | 0.39 | |||||
| 5-Year Yield-on-Cost % | 0.39 | |||||
| 3-Year Average Share Buyback Ratio | -10.8 | |||||
| Shareholder Yield % | 0.21 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.38 | |||||
| Operating Margin % | 19.21 | |||||
| Net Margin % | 16.78 | |||||
| FCF Margin % | 9.7 | |||||
| ROE % | 12.69 | |||||
| ROA % | 10.18 | |||||
| ROIC % | 39.13 | |||||
| ROC (Joel Greenblatt) % | 881.78 | |||||
| ROCE % | 15.07 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.6 | |||||
| PE Ratio without NRI | 19.39 | |||||
| Price-to-Owner-Earnings | 21.5 | |||||
| PEG Ratio | 0.84 | |||||
| PS Ratio | 3.45 | |||||
| PB Ratio | 2.49 | |||||
| Price-to-Tangible-Book | 2.5 | |||||
| Price-to-Free-Cash-Flow | 35.66 | |||||
| Price-to-Operating-Cash-Flow | 30.75 | |||||
| EV-to-EBIT | 11.83 | |||||
| EV-to-EBITDA | 11.83 | |||||
| EV-to-Revenue | 2.37 | |||||
| EV-to-FCF | 24.38 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.83 | |||||
| Price-to-Graham-Number | 1.47 | |||||
| Price-to-Net-Current-Asset-Value | 2.59 | |||||
| Price-to-Net-Cash | 4.31 | |||||
| Earnings Yield (Greenblatt) % | 8.45 | |||||
| FCF Yield % | 2.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SMO Clinplus Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 787.423 | ||
| EPS (TTM) (Â¥) | 2.19 | ||
| Beta | 0 | ||
| Volatility % | 49.28 | ||
| 14-Day RSI | 44.83 | ||
| 14-Day ATR (Â¥) | 2.245279 | ||
| 20-Day SMA (Â¥) | 46.5395 | ||
| 12-1 Month Momentum % | -41.31 | ||
| 52-Week Range (Â¥) | 33.6 - 82.4 | ||
| Shares Outstanding (Mil) | 61.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SMO Clinplus Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SMO Clinplus Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
SMO Clinplus Co Ltd Frequently Asked Questions
What is SMO Clinplus Co Ltd(SZSE:301257)'s stock price today?
The current price of SZSE:301257 is ¥45.11. The 52 week high of SZSE:301257 is ¥82.40 and 52 week low is ¥33.60.
When is next earnings date of SMO Clinplus Co Ltd(SZSE:301257)?
The next earnings date of SMO Clinplus Co Ltd(SZSE:301257) is .
Does SMO Clinplus Co Ltd(SZSE:301257) pay dividends? If so, how much?
The Dividend Yield %  of SMO Clinplus Co Ltd(SZSE:301257) is 0.39% (As of Today), Highest Dividend Payout Ratio of SMO Clinplus Co Ltd(SZSE:301257) was 0.08. The lowest was 0.08. And the median was 0.08. The  Forward Dividend Yield % of SMO Clinplus Co Ltd(SZSE:301257) is 0.39%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers